OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthetic Biology: Emerging Concepts to Design and Advance Adeno‐Associated Viral Vectors for Gene Therapy
Hanna J. Wagner, Wilfried Weber, Martin Fussenegger
Advanced Science (2021) Vol. 8, Iss. 9
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Chemically Modified Platforms for Better RNA Therapeutics
Yesi Shi, Xueyan Zhen, Yiming Zhang, et al.
Chemical Reviews (2024) Vol. 124, Iss. 3, pp. 929-1033
Closed Access | Times Cited: 34

Engineering Self-Assembling Protein Nanoparticles for Therapeutic Delivery
Audrey Olshefsky, C. Peter Richardson, Suzie H. Pun, et al.
Bioconjugate Chemistry (2022) Vol. 33, Iss. 11, pp. 2018-2034
Open Access | Times Cited: 49

Adeno-Associated Virus (AAV)-Mediated Gene Therapy for Duchenne Muscular Dystrophy: The Issue of Transgene Persistence
Arianna Manini, Elena Abati, Andi Nuredini, et al.
Frontiers in Neurology (2022) Vol. 12
Open Access | Times Cited: 46

Genetic engineering of bacteriophages: Key concepts, strategies, and applications
Wajid Hussain, Xiaohan Yang, Mati Ullah, et al.
Biotechnology Advances (2023) Vol. 64, pp. 108116-108116
Closed Access | Times Cited: 23

Systems biology approaches to identify driver genes and drug combinations for treating COVID-19
Ali Ebrahimi, Farinaz Roshani
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5

Delivery of DNA-Based Therapeutics for Treatment of Chronic Diseases
Carleigh Sussman, Rachel A. Liberatore, M. Dróżdż
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 535-535
Open Access | Times Cited: 5

AAV-delivered muscone-induced transgene system for treating chronic diseases in mice via inhalation
Xin Wu, Yuanhuan Yu, Meiyan Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4

Chemical approaches to probe and engineer AAV vectors
Quan Pham, Jake Glicksman, Abhishek Chatterjee
Nanoscale (2024) Vol. 16, Iss. 29, pp. 13820-13833
Open Access | Times Cited: 4

Gene Therapy in Hemophilia: Recent Advances
E. Carlos Rodríguez‐Merchán, Juan A. De Pablo-Moreno, Antonio Liras
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 14, pp. 7647-7647
Open Access | Times Cited: 37

Hemophilia Healing with AAV: Navigating the Frontier of Gene Therapy
Safir Ullah Khan, Munir Ullah Khan, Muhammad Suleman, et al.
Current Gene Therapy (2024) Vol. 24, Iss. 4, pp. 265-277
Closed Access | Times Cited: 3

Rational engineering of a functional CpG-free ITR for AAV gene therapy
Xiufang Pan, Yongping Yue, Maria Boftsi, et al.
Gene Therapy (2021) Vol. 29, Iss. 6, pp. 333-345
Open Access | Times Cited: 30

Ultrastructure of dorsal root ganglia
Rainer Haberberger, Jaliya Kuramatilake, Christine Barry, et al.
Cell and Tissue Research (2023) Vol. 393, Iss. 1, pp. 17-36
Open Access | Times Cited: 9

Spatiotemporally confined red light-controlled gene delivery at single-cell resolution using adeno-associated viral vectors
Maximilian Hörner, Carolina Jerez‐Longres, Anna Hudek, et al.
Science Advances (2021) Vol. 7, Iss. 25
Open Access | Times Cited: 24

Unraveling the potential of M13 phages in biomedicine: Advancing drug nanodelivery and gene therapy
Mahmood Fadaie, Hassan Dianat‐Moghadam, Elham Ghafouri, et al.
Environmental Research (2023) Vol. 238, pp. 117132-117132
Closed Access | Times Cited: 8

Molecular Signature of Astrocytes for Gene Delivery by the Synthetic Adeno‐Associated Viral Vector rAAV9P1
Amelie Bauer, Matteo Puglisi, Dennis Nagl, et al.
Advanced Science (2022) Vol. 9, Iss. 16
Open Access | Times Cited: 12

BMAL1-TTK-H2Bub1 loop deficiency contributes to impaired BM-MSC-mediated bone formation in senile osteoporosis
Li Jinteng, Xu Peitao, YU Wenhui, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 31, pp. 568-585
Open Access | Times Cited: 6

Harnessing synthetic biology for advancing RNA therapeutics and vaccine design
Blaine A. Pfeifer, Marie Beitelshees, Andrew Hill, et al.
npj Systems Biology and Applications (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 6

Cellular uptake, tissue penetration, biodistribution, and biosafety of threose nucleic acids: Assessing in vitro and in vivo delivery
Fei Wang, Ling Sum Liu, Pan Li, et al.
Materials Today Bio (2022) Vol. 15, pp. 100299-100299
Open Access | Times Cited: 9

miRNA Pathway Alteration in Response to Non-Coding RNA Delivery in Viral Vector-Based Gene Therapy
Darya A. Savenkova, A. A. Makarova, Igor K. Shalik, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14954-14954
Open Access | Times Cited: 9

Structural materials meet synthetic biology in biomedical applications
Xiaoxuan Zhang, Martin Fussenegger
Materials Today (2023) Vol. 72, pp. 163-182
Open Access | Times Cited: 3

Adeno-Associated Viruses for Modeling Neurological Diseases in Animals: Achievements and Prospects
Evgenii A. Lunev, Anna A. Karan, Tatiana V. Egorova, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1140-1140
Open Access | Times Cited: 6

Living virus‐based nanohybrids for biomedical applications
Lulu Jin, Zhengwei Mao
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 2

Page 1 - Next Page

Scroll to top